Selected for the inaugural cohort of the Solara Growth DeepTech Accelerator, an execution and investment focused program supporting breakthrough DeepTech startups across healthcare, defense, and climate. A meaningful milestone as we continue building the future of Surgical AI at Nuevata.

Nuevata has been selected for the highly competitive India Deep Tech Accelerator powered by the Polsky Center for Entrepreneurship and Innovation at the University of Chicago. The 10‑week program supports globally ambitious deep‑tech startups through targeted workshops, U.S. market access, investor connections, and showcase opportunities in India and the Bay Area.

Nuevata has been onboarded into Microsoft for Startups, gaining access to Azure cloud credits, AI infrastructure, technical mentorship, and global go‑to‑market support. This partnership strengthens our mission to build a secure, scalable surgical intelligence platform and accelerate deployment across hospitals worldwide.

Full software platform launched across Web App, Mobile App, Student Portal, and Admin Portal. Available at app.nuevata.com. Platform supports surgical video capture, annotation, analytics, and collaborative review.

Nuevata selected for GINCELERATOR 3.0, a flagship Government of India (DST–NIDHI) healthtech accelerator. Program provides direct access to clinical environments, hospital networks, investor readiness support, and structured scale infrastructure.

Final industrial design mockup of the Iris head-mounted 4K capture device demonstrated publicly at Surgical AI Days 2026, Ghent, Belgium receiving validation from surgical AI researchers across Johns Hopkins, UCL, Imperial College, NUS Singapore, and TU Dresden.

Electronics Manufacturing Services (EMS) and injection-moulded plastics vendors selected and contracts initiated for Iris hardware production completing the supply chain foundation for device manufacturing.

Nuevata accepted into NVIDIA Inception, connecting the team to NVIDIA's global AI-first startup ecosystem, GPU compute resources, and strategic visibility within the medical AI community.

Brand name NUEVATA™ successfully trademarked across Classes 9, 10, 38, and 42 covering medical devices, software, telecommunications, and technology services. Intellectual property foundation secured.

Closed pre-seed funding of INR 1 Crore to fund hardware prototype development, software platform build, and a 30-person hybrid development team. Round validates early investor confidence in the surgical intelligence thesis.

Nuevata recognised by the Department for Promotion of Industry and Internal Trade, Ministry of Commerce and Industry, Government of India enabling access to IP fast-tracking, tax benefits, and public procurement priority.

Nuevata Innovations Pvt. Ltd. formally incorporated in India (CIN: U32509TS2025PTC198027), with founding team in place: Prashanth Ray (CEO), Ramakanth Ileni (CTO), Dr. Hema Anukula (CMO).

First head-mounted capture prototype tested in active operating rooms at India's leading hospitals, with direct surgeon feedback informing hardware ergonomics and optics requirements.

Conducted structured discovery interviews across 100+ hospitals in India, engaging 500+ surgeons to validate the pain points of surgical documentation, training, and performance feedback.

Co-founders attended 30+ live open surgeries across AIG Hospitals and Apollo Hospitals to map intraoperative workflow gaps firsthand. This clinical immersion formed the product specification for Nuevata Iris and Nuevata Platform.